Testing Pulse Stimulation to Improve Motor Function in People With ALS: A Pilot Study
NCT06681610 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2024-11-08
Summary
The goal of this clinical trial is to assess the efficacy of TPS of the motor cortex on biomarkers and clinical endpoints in patients with ALS. The main questions it aims to answer are:
* Stage 1: Is there a change in the short intracortical inhibition (SICI) of the motor cortex from baseline to week 8?
* Stage 2: Is there a change from baseline to month 6 in the ALS functional rating scale-revised (ALSFRS-R) total score?
In stage 2, researchers will compare the group receiving the stimulation vs the group receiving a sham stimulation to see if there is a difference in motor cortex activity and in the ALSFRS-R score
Participants will receive either:
* the TPS treatment
* a sham TPS treatment
Conditions
- Amyotrophic Lateral Sclerosis (ALS)
Interventions
- DEVICE
-
Transcranial Pulse Stimulation
low intensity shock-waves stimulation of the motor cortex, bilateral
Sponsors & Collaborators
-
Parc de Salut Mar
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 21 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-24
- Primary Completion
- 2025-04-30
- Completion
- 2026-12-31
Countries
- Spain
Study Locations
More Related Trials
-
At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis
NCT07006571 ·Status: RECRUITING ·Phase: NA
-
Non-invasive Brain Stimulation and Exercise Intervention for Patients With Motor Neuron Disease
NCT07067229 ·Status: RECRUITING ·Phase: NA
-
Human Neural Stem Cell Transplantation in Amyotrophic Lateral Sclerosis (ALS)
NCT01640067 ·Status: COMPLETED ·Phase: PHASE1
-
Assessing Motor Neuron Disease Mechanisms by Threshold Tracking Transcranial Magnetic Stimulation and Magnetic Resonance Spectroscopy
NCT03664206 ·Status: WITHDRAWN
-
Exercise and Disease Progression in Amyotrophic Lateral Sclerosis Patients
NCT03326622 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS) Who Met Severity Classification III
NCT00415519 ·Status: COMPLETED ·Phase: PHASE3
-
Cortico-Spinal tDCS as Rehabilitative Intervention in Amyotrophic Lateral Sclerosis
NCT04293484 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial on the Use of Cell Therapy in the Treatment of Patients With Amyotrophic Lateral Sclerosis
NCT04849065 ·Status: UNKNOWN ·Phase: PHASE2
-
Video-Based Proprioceptive Exercise Program in ALS
NCT07292545 ·Status: RECRUITING ·Phase: NA
-
Transcranial Direct Current Stimulation as a Novel Therapeutic Approach in Amyotrophic Lateral Sclerosis
NCT01569958 ·Status: UNKNOWN ·Phase: PHASE2
-
The Safety, Tolerability and Preliminary Efficacy of Derived Motor Neuron Progenitor Cells (XS228CN) in Subjects With Amyotrophic Lateral Sclerosis
NCT07118319 ·Status: RECRUITING ·Phase: PHASE1
-
Efficacy and Safety Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis (ALS)
NCT00330681 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS)
NCT01521728 ·Status: COMPLETED ·Phase: NA
-
Rehabilitative Trial With tDCS in Amyotrophic Lateral Sclerosis
NCT03293394 ·Status: COMPLETED ·Phase: NA
-
G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
NCT00397423 ·Status: COMPLETED ·Phase: PHASE2
-
Nocturnal PtcCO2 Monitoring in Patients With Amyotrophic Lateral Sclerosis (ALS)
NCT00879593 ·Status: COMPLETED ·Phase: NA
-
Study of the Effects Strengthening Exercises in Individuals With ALS
NCT00204464 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
NCT01730716 ·Status: UNKNOWN ·Phase: PHASE2
-
Exploring Nasal Drop Therapy With Small Extracellular Vesicles for ALS
NCT06598202 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Clinical Trial on the Use of Autologous Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis
NCT00855400 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Nerve Growth Factor Encapsulated With 2-methacryloyloxyethyl Phosphorylcholine Nanocapsules in the Treatment of Amyotrophic Lateral Sclerosis
NCT06391645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
A Pilot Study of the Utility of 3D Printed Masks for ALS Subjects
NCT03519880 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
NCT03127267 ·Status: RECRUITING ·Phase: PHASE3
-
Methodology Study of Novel Outcome Measures to Assess Progression of ALS
NCT02611674 ·Status: COMPLETED
-
Efficacy and Safety of Tazbentetol in ALS Participants
NCT07325591 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3